US approves biosimilar filgrastim
Wednesday, March 11, 2015 - 06:30
in Mathematics & Economics
Sandoz’s version of Amgen’s Neupogen is ‘biosimilar’ but not ‘interchangeable’
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via